NCT00910351View on ClinicalTrials.gov

Cipro Inhaler for Cystic Fibrosis Children Ages 6-12

PHASE1CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Pseudomonas Infection

Interventions

DRUG

Ciprofloxacin (Cipro, BAYQ3939)

25 mg inhaled Ciprofloxacin

Trial Locations (4)

13210

Syracuse

21287

Baltimore

30322

Atlanta

02115

Boston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY